Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
British Journal of Cancer
|
April 23, 2005
Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells
E Hofsli, L Thommesen, F Yadetie, et al.
British Journal of Cancer
|
April 6, 2013
Identification of serum microRNA profiles in colon cancer
E Hofsli, W Sjursen, W S Prestvik, et al.
British Journal of Cancer
|
December 10, 2021
Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
S G Larsen, M A Goscinski, S Dueland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 13, 2012
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study
H Sorbye, S Welin, S W Langer, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
British Journal of Cancer
|
April 23, 2005
Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells
E Hofsli, L Thommesen, F Yadetie, et al.
British Journal of Cancer
|
April 6, 2013
Identification of serum microRNA profiles in colon cancer
E Hofsli, W Sjursen, W S Prestvik, et al.
British Journal of Cancer
|
December 10, 2021
Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
S G Larsen, M A Goscinski, S Dueland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 13, 2012
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study
H Sorbye, S Welin, S W Langer, et al.
Page
of 3